
Therapeutic Segment
Antidiabetic
CAS No.
842133-18-0
Regulatory Filing
-
Development Status
Under development
Molecule Type
Small Molecule
Mechanism of Action
Sodium-glucose co-transporter 2 (SGLT2) inhibitor